Search

Your search keyword '"Golan, Eyal"' showing total 38 results
Start Over Author "Golan, Eyal"
38 results on '"Golan, Eyal"'

4. Part 4: Advanced life support: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations

Author

Andersen, Lars W., Berg, Katherine M., Sandroni, Claudio, Lin, Steve, Lavonas, Eric J., Golan, Eyal, Alhelail, Mohammed A., Chopra, Amit, Cocchi, Michael N., Cronberg, Tobias, Dainty, Katie N., Drennan, Ian R., Fries, Michael, Geocadin, Romergryko G., Gräsner, Jan-Thorsten, Granfeldt, Asger, Heikal, Sarah, Kudenchuk, Peter J., Lagina, Anthony T., III, Løfgren, Bo, Mhyre, Jill, Monsieurs, Koenraad G., Mottram, Allan R., Pellis, Tommaso, Reynolds, Joshua C., Ristagno, Giuseppe, Severyn, Fred A., Skrifvars, Markus, Stacey, William C., Sullivan, Jonathon, Todhunter, Sarah L., Vissers, Gino, West, Stephen, Wetsch, Wolfgang A., Wong, Natalie, Xanthos, Theodoros, Zelop, Carolyn M., Zimmerman, Janice, Soar, Jasmeet, Callaway, Clifton W., Aibiki, Mayuki, Böttiger, Bernd W., Brooks, Steven C., Deakin, Charles D., Donnino, Michael W., Drajer, Saul, Kloeck, Walter, Morley, Peter T., Morrison, Laurie J., Neumar, Robert W., Nicholson, Tonia C., Nolan, Jerry P., Okada, Kazuo, O’Neil, Brian J., Paiva, Edison F., Parr, Michael J., Wang, Tzong-Luen, and Witt, Jonathan

Published
2015
Full Text
View/download PDF

10. Soutien des familles en deuil par les intervenants aux soins intensifs : une étude de méthodes mixtes.

Author

Kalocsai, Csilla, des Ordons, Amanda Roze, Sinuff, Tasnim, Koo, Ellen, Smith, Orla, Cook, Deborah, Golan, Eyal, Hales, Sarah, Tomlinson, George, Strachan, Derek, MacKinnon, Christopher J., and Downar, James

Subjects
FAMILIES, CRITICAL care medicine, BEREAVEMENT
Abstract

Copyright of Canadian Journal of Anaesthesia / Journal Canadien d'Anesthésie is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2020
Full Text
View/download PDF

11. Canadian Guidelines for the use of targeted temperature management (therapeutic hypothermia) after cardiac arrest: A joint statement from The Canadian Critical Care Society (CCCS), Canadian Neurocritical Care Society (CNCCS), and the Canadian Critical Care Trials Group (CCCTG)

Author

Howes, Daniel, Gray, Sara H., Brooks, Steven C., Boyd, J. Gordon, Djogovic, Dennis, Golan, Eyal, Green, Robert S., Jacka, Michael J., Sinuff, Tasnim, Chaplin, Timothy, Smith, Orla M., Owen, Julian, Szulewski, Adam, Murphy, Laurel, Irvine, Stephanie, Jichici, Draga, and Muscedere, John

Published
2016
Full Text
View/download PDF

12. Prevalence and predictors of severe grief reactions and desire for support following a death in the intensive care unit: a multicentre observational study

Author

Downar, James, primary, Koo, Ellen, additional, des Ordons, Amanda Roze, additional, Smith, Orla, additional, Cook, Deborah, additional, Golan, Eyal, additional, Hales, Sarah, additional, Tomlinson, George, additional, Kalocsai, Csilla, additional, Strachan, Derek, additional, MacKinnon, Christopher, additional, and Sinuff, Tasnim, additional

Published
2017
Full Text
View/download PDF

15. E01-C Developing an Intensive Care Unit Clinician-Led BEREAVEment Screening and Support Program for ICU Family Members (ICU BEREAVE)

Author

Koo, Ellen, primary, Kalocsai, Csilla, additional, Sinuff, Tasnim, additional, Roze des Ordons, Amanda, additional, Smith, Orla, additional, Cook, Deborah, additional, Golan, Eyal, additional, Hales, Sarah, additional, Strachan, Derek, additional, MacKinnon, Christopher, additional, and Downar, James, additional

Published
2016
Full Text
View/download PDF

18. Advanced life support 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations

Author

J, Soar, Cw, Callaway, M, Aibiki, Bw, Bottiger, Sc, Brook, Cd, Deakin, Mw, Donnino, S, Drajer, W, Kloeck, Pt, Morley, Lj, Morrison, Rw, Neumar, Tc, Nicholson, Jp, Nolan, K, Okada, Bj, O'Neil, Ef, Paiva, Mj, Parr, Tl, Wang, J, Witt, W Andersen, Lar, M Berg, Katherine, Sandroni, Claudio, Lin, Steve, J Lavonas, Eric, Golan, Eyal, A Alhelail, Mohammed, Chopra, Amit, N Cocchi, Michael, Cronberg, Tobia, N Dainty, Katie, R Drennan, Ian, Fries, Michael, G Geocadin, Romergryko, Gräsner, Jan-Thorsten, Granfeldt, Asger, Heikal, Sarah, J Kudenchuk, Peter, T Lagina 3rd, Anthony, Løfgren, Bo, Mhyre, Jill, G Monsieurs, Koenraad, R Mottram, Allan, Pellis, Tommaso, C Reynolds, Joshua, Ristagno, Giuseppe, A Severyn, Fred, Skrifvars, Marku, C Stacey, William, Sullivan, Jonathon, L Todhunter, Sarah, Vissers, Gino, West, Stephen, A Wetsch, Wolfgang, Wong, Natalie, Xanthos, Theodoro, M Zelop, Carolyn, Zimmerman, Janice, Claudio Sandroni (ORCID:0000-0002-8878-2611), J, Soar, Cw, Callaway, M, Aibiki, Bw, Bottiger, Sc, Brook, Cd, Deakin, Mw, Donnino, S, Drajer, W, Kloeck, Pt, Morley, Lj, Morrison, Rw, Neumar, Tc, Nicholson, Jp, Nolan, K, Okada, Bj, O'Neil, Ef, Paiva, Mj, Parr, Tl, Wang, J, Witt, W Andersen, Lar, M Berg, Katherine, Sandroni, Claudio, Lin, Steve, J Lavonas, Eric, Golan, Eyal, A Alhelail, Mohammed, Chopra, Amit, N Cocchi, Michael, Cronberg, Tobia, N Dainty, Katie, R Drennan, Ian, Fries, Michael, G Geocadin, Romergryko, Gräsner, Jan-Thorsten, Granfeldt, Asger, Heikal, Sarah, J Kudenchuk, Peter, T Lagina 3rd, Anthony, Løfgren, Bo, Mhyre, Jill, G Monsieurs, Koenraad, R Mottram, Allan, Pellis, Tommaso, C Reynolds, Joshua, Ristagno, Giuseppe, A Severyn, Fred, Skrifvars, Marku, C Stacey, William, Sullivan, Jonathon, L Todhunter, Sarah, Vissers, Gino, West, Stephen, A Wetsch, Wolfgang, Wong, Natalie, Xanthos, Theodoro, M Zelop, Carolyn, Zimmerman, Janice, and Claudio Sandroni (ORCID:0000-0002-8878-2611)

Abstract

N/A

Published
2015

19. Part 8: Post–Cardiac Arrest Care

Author

Callaway, Clifton W., primary, Donnino, Michael W., additional, Fink, Ericka L., additional, Geocadin, Romergryko G., additional, Golan, Eyal, additional, Kern, Karl B., additional, Leary, Marion, additional, Meurer, William J., additional, Peberdy, Mary Ann, additional, Thompson, Trevonne M., additional, and Zimmerman, Janice L., additional

Published
2015
Full Text
View/download PDF

20. Part 4: Advanced Life Support

Author

Callaway, Clifton W., primary, Soar, Jasmeet, additional, Aibiki, Mayuki, additional, Böttiger, Bernd W., additional, Brooks, Steven C., additional, Deakin, Charles D., additional, Donnino, Michael W., additional, Drajer, Saul, additional, Kloeck, Walter, additional, Morley, Peter T., additional, Morrison, Laurie J., additional, Neumar, Robert W., additional, Nicholson, Tonia C., additional, Nolan, Jerry P., additional, Okada, Kazuo, additional, O’Neil, Brian J., additional, Paiva, Edison F., additional, Parr, Michael J., additional, Wang, Tzong-Luen, additional, Witt, Jonathan, additional, Andersen, Lars W., additional, Berg, Katherine M., additional, Sandroni, Claudio, additional, Lin, Steve, additional, Lavonas, Eric J., additional, Golan, Eyal, additional, Alhelail, Mohammed A., additional, Chopra, Amit, additional, Cocchi, Michael N., additional, Cronberg, Tobias, additional, Dainty, Katie N., additional, Drennan, Ian R., additional, Fries, Michael, additional, Geocadin, Romergryko G., additional, Gräsner, Jan-Thorsten, additional, Granfeldt, Asger, additional, Heikal, Sarah, additional, Kudenchuk, Peter J., additional, Lagina, Anthony T., additional, Løfgren, Bo, additional, Mhyre, Jill, additional, Monsieurs, Koenraad G., additional, Mottram, Allan R., additional, Pellis, Tommaso, additional, Reynolds, Joshua C., additional, Ristagno, Giuseppe, additional, Severyn, Fred A., additional, Skrifvars, Markus, additional, Stacey, William C., additional, Sullivan, Jonathon, additional, Todhunter, Sarah L., additional, Vissers, Gino, additional, West, Stephen, additional, Wetsch, Wolfgang A., additional, Wong, Natalie, additional, Xanthos, Theodoros, additional, Zelop, Carolyn M., additional, and Zimmerman, Janice, additional

Published
2015
Full Text
View/download PDF

21. Part 4: Advanced life support

Author

Soar, Jasmeet, primary, Callaway, Clifton W., additional, Aibiki, Mayuki, additional, Böttiger, Bernd W., additional, Brooks, Steven C., additional, Deakin, Charles D., additional, Donnino, Michael W., additional, Drajer, Saul, additional, Kloeck, Walter, additional, Morley, Peter T., additional, Morrison, Laurie J., additional, Neumar, Robert W., additional, Nicholson, Tonia C., additional, Nolan, Jerry P., additional, Okada, Kazuo, additional, O’Neil, Brian J., additional, Paiva, Edison F., additional, Parr, Michael J., additional, Wang, Tzong-Luen, additional, Witt, Jonathan, additional, Andersen, Lars W., additional, Berg, Katherine M., additional, Sandroni, Claudio, additional, Lin, Steve, additional, Lavonas, Eric J., additional, Golan, Eyal, additional, Alhelail, Mohammed A., additional, Chopra, Amit, additional, Cocchi, Michael N., additional, Cronberg, Tobias, additional, Dainty, Katie N., additional, Drennan, Ian R., additional, Fries, Michael, additional, Geocadin, Romergryko G., additional, Gräsner, Jan-Thorsten, additional, Granfeldt, Asger, additional, Heikal, Sarah, additional, Kudenchuk, Peter J., additional, Lagina, Anthony T., additional, Løfgren, Bo, additional, Mhyre, Jill, additional, Monsieurs, Koenraad G., additional, Mottram, Allan R., additional, Pellis, Tommaso, additional, Reynolds, Joshua C., additional, Ristagno, Giuseppe, additional, Severyn, Fred A., additional, Skrifvars, Markus, additional, Stacey, William C., additional, Sullivan, Jonathon, additional, Todhunter, Sarah L., additional, Vissers, Gino, additional, West, Stephen, additional, Wetsch, Wolfgang A., additional, Wong, Natalie, additional, Xanthos, Theodoros, additional, Zelop, Carolyn M., additional, and Zimmerman, Janice, additional

Published
2015
Full Text
View/download PDF

23. Nonbeneficial Treatment Canada

Author

Downar, James, primary, You, John J., additional, Bagshaw, Sean M., additional, Golan, Eyal, additional, Lamontagne, Francois, additional, Burns, Karen, additional, Sridhar, S. Kavita, additional, Seely, Andrew, additional, Meade, Maureen O., additional, Fox-Robichaud, Alison, additional, Cook, Deborah, additional, Turgeon, Alexis F., additional, Dodek, Peter, additional, Xiong, Wei, additional, and Fowler, Rob, additional

Published
2015
Full Text
View/download PDF

29. Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial-PROSPECT: a pilot trial.

Author

Cook, Deborah J., Johnstone, Jennie, Marshall, John C., Lauzier, Francois, Thabane, Lehana, Mehta, Sangeeta, Dodek, Peter M., McIntyre, Lauralyn, Pagliarello, Joe, Henderson, William, Taylor, Robert W., Cartin-Ceba, Rodrigo, Golan, Eyal, Herridge, Margaret, Wood, Gordon, Ovakim, Daniel, Karachi, Tim, Surette, Michael G., Bowdish, Dawn M. E., and Lamarche, Daphnee

Subjects
THERAPEUTIC use of probiotics, PNEUMONIA prevention, MECHANICAL ventilators, COMPETITIVE exclusion (Microbiology), TRACHEAL diseases, PNEUMONIA diagnosis, PNEUMONIA-related mortality, COMPARATIVE studies, LENGTH of stay in hospitals, INTENSIVE care units, LACTOBACILLUS, RESEARCH methodology, MEDICAL cooperation, PNEUMONIA, RESEARCH, TIME, TRACHEA, TRACHEA intubation, PILOT projects, EVALUATION research, RANDOMIZED controlled trials, PROBIOTICS, TREATMENT effectiveness, SEVERITY of illness index, HOSPITAL mortality, DIAGNOSIS, VENTILATOR-associated pneumonia, PREVENTION
Abstract

Background: Probiotics are live microorganisms that may confer health benefits when ingested. Randomized trials suggest that probiotics significantly decrease the incidence of ventilator-associated pneumonia (VAP) and the overall incidence of infection in critically ill patients. However, these studies are small, largely single-center, and at risk of bias. The aim of the PROSPECT pilot trial was to determine the feasibility of conducting a larger trial of probiotics to prevent VAP in mechanically ventilated patients in the intensive care unit (ICU).Methods: In a randomized blinded trial, patients expected to be mechanically ventilated for ≥72 hours were allocated to receive either 1 × 10(10) colony-forming units of Lactobacillus rhamnosus GG or placebo, twice daily. Patients were excluded if they were at increased risk of L. rhamnosus GG infection or had contraindications to enteral medication. Feasibility objectives were: (1) timely recruitment; (2) maximal protocol adherence; (3) minimal contamination; and (4) estimated VAP rate ≥10 %. We also measured other infections, diarrhea, ICU and hospital length of stay, and mortality.Results: Overall, in 14 centers in Canada and the USA, all feasibility goals were met: (1) 150 patients were randomized in 1 year; (2) protocol adherence was 97 %; (3) no patients received open-label probiotics; and (4) the VAP rate was 19 %. Other infections included: bloodstream infection (19.3 %), urinary tract infections (12.7 %), and skin and soft tissue infections (4.0 %). Diarrhea, defined as Bristol type 6 or 7 stools, occurred in 133 (88.7 %) of patients, the median length of stay in ICU was 12 days (quartile 1 to quartile 3, 7-18 days), and in hospital was 26 days (quartile 1 to quartile 3, 14-44 days); 23 patients (15.3 %) died in the ICU.Conclusions: The PROSPECT pilot trial supports the feasibility of a larger trial to investigate the effect of L. rhamnosus GG on VAP and other nosocomial infections in critically ill patients.Trial Registration: Clinicaltrials.gov NCT01782755 . Registered on 29 January 2013. [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

32. Traumatic Brain Injury in Intoxicated Patients

Author

Golan, Jeff Dror, primary, Marcoux, Judith, additional, Golan, Eyal, additional, Schapiro, Robert, additional, Johnston, Karen M., additional, Maleki, Mahammed, additional, Khetarpal, Suneel, additional, and Jacques, Line, additional

Published
2007
Full Text
View/download PDF

35. Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial—PROSPECT: a pilot trial

Author

Cook, Deborah J, Johnstone, Jennie, Marshall, John C, Lauzier, Francois, Thabane, Lehana, Mehta, Sangeeta, Dodek, Peter M, McIntyre, Lauralyn, Pagliarello, Joe, Henderson, William, Taylor, Robert W, Cartin-Ceba, Rodrigo, Golan, Eyal, Herridge, Margaret, Wood, Gordon, Ovakim, Daniel, Karachi, Tim, Surette, Michael G, Bowdish, Dawn M E, Lamarche, Daphnee, Verschoor, Chris P, Duan, Erick H, Heels-Ansdell, Diane, Arabi, Yaseen, and Meade, Maureen

Subjects
3. Good health
Abstract

Background: Probiotics are live microorganisms that may confer health benefits when ingested. Randomized trials suggest that probiotics significantly decrease the incidence of ventilator-associated pneumonia (VAP) and the overall incidence of infection in critically ill patients. However, these studies are small, largely single-center, and at risk of bias. The aim of the PROSPECT pilot trial was to determine the feasibility of conducting a larger trial of probiotics to prevent VAP in mechanically ventilated patients in the intensive care unit (ICU). Methods: In a randomized blinded trial, patients expected to be mechanically ventilated for ≥72 hours were allocated to receive either 1 × 1010 colony-forming units of Lactobacillus rhamnosus GG or placebo, twice daily. Patients were excluded if they were at increased risk of L. rhamnosus GG infection or had contraindications to enteral medication. Feasibility objectives were: (1) timely recruitment; (2) maximal protocol adherence; (3) minimal contamination; and (4) estimated VAP rate ≥10 %. We also measured other infections, diarrhea, ICU and hospital length of stay, and mortality. Results: Overall, in 14 centers in Canada and the USA, all feasibility goals were met: (1) 150 patients were randomized in 1 year; (2) protocol adherence was 97 %; (3) no patients received open-label probiotics; and (4) the VAP rate was 19 %. Other infections included: bloodstream infection (19.3 %), urinary tract infections (12.7 %), and skin and soft tissue infections (4.0 %). Diarrhea, defined as Bristol type 6 or 7 stools, occurred in 133 (88.7 %) of patients, the median length of stay in ICU was 12 days (quartile 1 to quartile 3, 7–18 days), and in hospital was 26 days (quartile 1 to quartile 3, 14–44 days); 23 patients (15.3 %) died in the ICU. Conclusions: The PROSPECT pilot trial supports the feasibility of a larger trial to investigate the effect of L. rhamnosus GG on VAP and other nosocomial infections in critically ill patients. Trial registration: Clinicaltrials.gov NCT01782755 . Registered on 29 January 2013.

36. Additional file 1: of Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trialâ PROSPECT: a pilot trial

Author

Cook, Deborah, Johnstone, Jennie, Marshall, John, Francois Lauzier, Lehana Thabane, Mehta, Sangeeta, Dodek, Peter, Lauralyn McIntyre, Pagliarello, Joe, Henderson, William, Taylor, Robert, Cartin-Ceba, Rodrigo, Golan, Eyal, Herridge, Margaret, Wood, Gordon, Ovakim, Daniel, Karachi, Tim, Surette, Michael, Bowdish, Dawn, Daphnee Lamarche, Verschoor, Chris, Duan, Erick, Heels-Ansdell, Diane, Arabi, Yaseen, and Meade, Maureen

Subjects
3. Good health
Abstract

PROSPECT pilot center research ethics board information. (DOCX 14 kb)

37. Additional file 1: of Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trialâ PROSPECT: a pilot trial

Author

Cook, Deborah, Johnstone, Jennie, Marshall, John, Francois Lauzier, Lehana Thabane, Mehta, Sangeeta, Dodek, Peter, Lauralyn McIntyre, Pagliarello, Joe, Henderson, William, Taylor, Robert, Cartin-Ceba, Rodrigo, Golan, Eyal, Herridge, Margaret, Wood, Gordon, Ovakim, Daniel, Karachi, Tim, Surette, Michael, Bowdish, Dawn, Daphnee Lamarche, Verschoor, Chris, Duan, Erick, Heels-Ansdell, Diane, Arabi, Yaseen, and Meade, Maureen

Subjects
3. Good health
Abstract

PROSPECT pilot center research ethics board information. (DOCX 14 kb)

38. Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial.

Author

Johnstone J, Meade M, Lauzier F, Marshall J, Duan E, Dionne J, Arabi YM, Heels-Ansdell D, Thabane L, Lamarche D, Surette M, Zytaruk N, Mehta S, Dodek P, McIntyre L, English S, Rochwerg B, Karachi T, Henderson W, Wood G, Ovakim D, Herridge M, Granton J, Wilcox ME, Goffi A, Stelfox HT, Niven D, Muscedere J, Lamontagne F, D'Aragon F, St-Arnaud C, Ball I, Nagpal D, Girard M, Aslanian P, Charbonney E, Williamson D, Sligl W, Friedrich J, Adhikari NK, Marquis F, Archambault P, Khwaja K, Kristof A, Kutsogiannis J, Zarychanski R, Paunovic B, Reeve B, Lellouche F, Hosek P, Tsang J, Binnie A, Trop S, Loubani O, Hall R, Cirone R, Reynolds S, Lysecki P, Golan E, Cartin-Ceba R, Taylor R, and Cook D

Subjects
Aged, Anti-Bacterial Agents adverse effects, Bacterial Infections prevention & control, Diarrhea prevention & control, Female, Humans, Intensive Care Units, Male, Middle Aged, Treatment Failure, Anti-Bacterial Agents therapeutic use, Lacticaseibacillus rhamnosus, Pneumonia, Ventilator-Associated prevention & control, Probiotics therapeutic use, Respiration, Artificial adverse effects
Abstract

Importance: Growing interest in microbial dysbiosis during critical illness has raised questions about the therapeutic potential of microbiome modification with probiotics. Prior randomized trials in this population suggest that probiotics reduce infection, particularly ventilator-associated pneumonia (VAP), although probiotic-associated infections have also been reported., Objective: To evaluate the effect of Lactobacillus rhamnosus GG on preventing VAP, additional infections, and other clinically important outcomes in the intensive care unit (ICU)., Design, Setting, and Participants: Randomized placebo-controlled trial in 44 ICUs in Canada, the United States, and Saudi Arabia enrolling adults predicted to require mechanical ventilation for at least 72 hours. A total of 2653 patients were enrolled from October 2013 to March 2019 (final follow-up, October 2020)., Interventions: Enteral L rhamnosus GG (1 × 1010 colony-forming units) (n = 1321) or placebo (n = 1332) twice daily in the ICU., Main Outcomes and Measures: The primary outcome was VAP determined by duplicate blinded central adjudication. Secondary outcomes were other ICU-acquired infections including Clostridioides difficile infection, diarrhea, antimicrobial use, ICU and hospital length of stay, and mortality., Results: Among 2653 randomized patients (mean age, 59.8 years [SD], 16.5 years), 2650 (99.9%) completed the trial (mean age, 59.8 years [SD], 16.5 years; 1063 women [40.1%.] with a mean Acute Physiology and Chronic Health Evaluation II score of 22.0 (SD, 7.8) and received the study product for a median of 9 days (IQR, 5-15 days). VAP developed among 289 of 1318 patients (21.9%) receiving probiotics vs 284 of 1332 controls (21.3%; hazard ratio [HR], 1.03 (95% CI, 0.87-1.22; P = .73, absolute difference, 0.6%, 95% CI, -2.5% to 3.7%). None of the 20 prespecified secondary outcomes, including other ICU-acquired infections, diarrhea, antimicrobial use, mortality, or length of stay showed a significant difference. Fifteen patients (1.1%) receiving probiotics vs 1 (0.1%) in the control group experienced the adverse event of L rhamnosus in a sterile site or the sole or predominant organism in a nonsterile site (odds ratio, 14.02; 95% CI, 1.79-109.58; P < .001)., Conclusions and Relevance: Among critically ill patients requiring mechanical ventilation, administration of the probiotic L rhamnosus GG compared with placebo, resulted in no significant difference in the development of ventilator-associated pneumonia. These findings do not support the use of L rhamnosus GG in critically ill patients., Trial Registration: ClinicalTrials.gov Identifier: NCT02462590.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results